Terms: = Uterine cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
129 results:
1. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA ABHD11-AS1 activates egfr signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
3. Increased Gene Expression of
Parida P; Lewis S; Sharan K; Kamal MV; Kumar NAN; Godkhindi VM; Varambally S; Rangnekar VM; Rao M; Damerla RR
Cells; 2023 Oct; 12(21):. PubMed ID: 37947608
[No Abstract] [Full Text] [Related]
4. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
5. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/Src.
Hoang LN; Lee SJ
Cell Signal; 2023 Aug; 108():110733. PubMed ID: 37257767
[TBL] [Abstract] [Full Text] [Related]
6. Histone Methyltransferase KMT2B Promotes Metastasis and Angiogenesis of Cervical cancer by Upregulating EGF Expression.
Zhao D; Yuan H; Fang Y; Gao J; Li H; Li M; Cong H; Zhang C; Liang Y; Li J; Yang H; Yao M; Du M; Tu H; Gan Y
Int J Biol Sci; 2023; 19(1):34-49. PubMed ID: 36594087
[TBL] [Abstract] [Full Text] [Related]
7. A Novel Prognostic Risk Model for Cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
8. erbb3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
Yang X; Chen Y; Li M; Zhu W
Sci Rep; 2022 May; 12(1):8112. PubMed ID: 35581263
[TBL] [Abstract] [Full Text] [Related]
9. Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non-Small Cell Lung cancer.
Porciuncula A; Morgado M; Gupta R; Syrigos K; Meehan R; Zacharek SJ; Frederick JP; Schalper KA
Clin Cancer Res; 2021 Nov; 27(22):6174-6183. PubMed ID: 34518312
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating erbb signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract] [Full Text] [Related]
11. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract] [Full Text] [Related]
12. Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
Liu T; Chen J; Du Q; Liu J; Chen M; Ooi S; Huang J; Wang W; Yao S
Pathol Res Pract; 2021 Jun; 222():153450. PubMed ID: 33962175
[TBL] [Abstract] [Full Text] [Related]
13. Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Slomovitz BM; Chelariu-Raicu A; Schmeler KM; Lu KH; Gershenson DM; Wolf J; Coleman RL
Int J Gynecol Cancer; 2020 Nov; 30(11):1733-1737. PubMed ID: 33020204
[TBL] [Abstract] [Full Text] [Related]
14. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
15. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract] [Full Text] [Related]
16. Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
Aydinlik S; Dere E; Ulukaya E
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):903-916. PubMed ID: 30825616
[TBL] [Abstract] [Full Text] [Related]
17. The role of lncRNAs in signaling pathway implicated in CC.
Yang M; Wang M; Li X; Xie Y; Xia X; Tian J; Zhang K; Tang A
J Cell Biochem; 2019 Mar; 120(3):2703-2712. PubMed ID: 30552693
[TBL] [Abstract] [Full Text] [Related]
18. Crosstalk between SOX2 and cytokine signaling in endometrial carcinoma.
Lee CJ; Sung PL; Kuo MH; Tsai MH; Wang CK; Pan ST; Chen YJ; Wang PH; Wen KC; Chou YT
Sci Rep; 2018 Dec; 8(1):17550. PubMed ID: 30510261
[TBL] [Abstract] [Full Text] [Related]
19. Novel targeted therapies in ovarian and uterine carcinosarcomas.
Han C; Altwerger G; Menderes G; Haines K; Feinberg J; Lopez S; Manzano A; Varughese J; Santin AD
Discov Med; 2018 Jun; 25(140):309-319. PubMed ID: 30021104
[TBL] [Abstract] [Full Text] [Related]
20. PDGFRA mRNA overexpression is associated with regional metastasis and reduced survival in oral squamous cell carcinoma.
Ong HS; Gokavarapu S; Tian Z; Li J; Xu Q; Zhang CP; Cao W
J Oral Pathol Med; 2018 Aug; 47(7):652-659. PubMed ID: 29660835
[TBL] [Abstract] [Full Text] [Related]
[Next]
